Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Steven A. Edmundowicz MD, MASGE Associate Editor

Scott J. Cotler MD Associate Editor

See All Experts

featured

Published in Gastroenterology

Journal Scan / Research · August 30, 2022

Latiglutenase Protects the Mucosa and Attenuates Symptoms in Patients With Celiac Disease Exposed to Gluten

Gastroenterology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Peter Green MD

Gastroenterology

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients with Celiac Disease Exposed to a Gluten Challenge

Gastroenterology 2022 Aug 02;[EPub Ahead of Print], JA Murray, JA Syage, TT Wu, MA Dickason, AG Ramos, C Van Dyke, I Horwath, PT Lavin, M Mäki, I Hujoel, KA Papadakis, AC Bledsoe, C Khosla, JA Sealey-Voyksner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Latiglutenase Protects the Mucosa and Attenuates Symptoms in Patients With Celiac Disease Exposed to Gluten

Additional Info

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients with Celiac Disease Exposed to a Gluten Challenge

Further Reading

PNPLA3 rs738409, Age, Diabetes, Sex, and Advanced Fibrosis Jointly Contribute to the Risk of Major Adverse Liver Outcomes in Patients With MASLD

Endoscopic Hemostasis With PuraStat for Colonic Diverticular Bleeding

Assessing the Pathophysiology of Crohn's-Like Disease of the Pouch Using Single-Cell Analysis of Mucosal Cells

Guidelines on the Pharmacological Management of Patients With Moderate to Severe Ulcerative Colitis

Infliximab Plus Azathioprine vs Azathioprine Alone in Patients With Acute Severe Ulcerative Colitis Responsive to IV Steroids

EsoGuard Plus EsoCheck for Non-Endoscopic Detection of Barrett's Esophagus

Pathophysiology, Diagnosis, and Management of Dumping Syndrome

Histological Predictors of Aggressive Recurrence of HCC After Liver Resection

Association Between Alcohol Consumption Levels and the Severity of MASLD

Once-Daily and Twice-Daily Topical Corticosteroids for Treating Patients With Eosinophilic Esophagitis

Outcomes of Using Subcutaneous Infliximab Biosimilar CT-P13 as Maintenance Therapy in Patients With IBD

Recently Updated